يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"QR100-130"', وقت الاستعلام: 1.32s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Medical Research Council (MRC), European Commission, National Institutes of Health (US), National Institute for Health Research (UK), NIHR Biomedical Research Centre (UK), Agence Nationale de la Recherche (France), Haut Conseil pour la Science et la Technologie (France), Métropole Européenne de Lille, Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Generalitat Valenciana, Hospital Dr Josep Trueta de Girona, Universitat de Girona (UdG), Instituto de Salud Carlos III [Madrid] (ISC), Università degli Studi di Roma Tor Vergata [Roma], Nottingham Trent University, Imperial College London, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Ecole Polytechnique Fédérale de Lausanne (EPFL), University of Rome TorVergata, Universitat de València (UV), CIBER de Epidemiología y Salud Pública (CIBERESP), Wake Forest School of Medicine [Winston-Salem], Wake Forest Baptist Medical Center, Metabolic functional (epi)genomics and molecular mechanisms involved in type 2 diabetes and related diseases - UMR 8199 - UMR 1283 (EGENODIA (GI3M)), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre National de la Recherche Scientifique (CNRS), CHU Lille, ANR-16-IDEX-0004,ULNE,ULNE(2016), ANR-18-IBHU-0001,PreciDIAB,PreciDIAB Institute, the holistic approach of personal diabets care(2018), Universitat de Girona [Girona], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Metabolic functional (epi)genomics and molecular mechanisms involved in type 2 diabetes and related diseases - UMR 8199 - UMR 1283 (GI3M), Institut Català de la Salut, [Mayneris-Perxachs J, Latorre J, Moreno-Navarrete JM, Arnoriaga-Rodríguez M, Puig J, Ricart W, Fernández-Real JM] Departament de Diabetis, Endocrinologia i Nutrició, Hospital Universitari de Girona Dr. Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. Departament de Ciències Mèdiques, Universitat de Girona, Girona. Institut d'Investigació Biomèdica de Girona (IDIBGi), Salt, Spain. CIBERobn Pathophysiology of Obesity and Nutrition, Instituto de Salud Carlos III, Girona, Spain. [Cardellini M, Davato F] Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. [Hoyles L] Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Exhibition Road, London, UK. Department of Bioscience, School of Science and Technology, Nottingham Trent University, Nottingham, UK, Hospital Universitari de Girona Dr Josep Trueta

    المصدر: Microbiome
    r-FISABIO. Repositorio Institucional de Producción Científica
    instname
    Digital.CSIC. Repositorio Institucional del CSIC
    Microbiome, 2021, 9, ⟨10.1186/s40168-021-01052-7⟩
    Microbiome, 2021, vol. 9, art.núm. 104
    Articles publicats (D-CM)
    DUGiDocs – Universitat de Girona
    r-FISABIO: Repositorio Institucional de Producción Científica
    Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
    Microbiome, BioMed Central, 2021, 9, ⟨10.1186/s40168-021-01052-7⟩
    Scientia
    Microbiome, Vol 9, Iss 1, Pp 1-18 (2021)

    مصطلحات موضوعية: Settore MED/09, Fetge -- Malalties, compuestos inorgánicos::compuestos de hierro::hierro dietético [COMPUESTOS QUÍMICOS Y DROGAS], drugs, Microbial ecology, Mice, Fetge, 0302 clinical medicine, nash, 1108 Medical Microbiology, Non-alcoholic Fatty Liver Disease, glucose, Esteatosi hepàtica, 2. Zero hunger, chemistry.chemical_classification, 0303 health sciences, biology, alcohol, QR100-130, Fatty liver, Digestive System Diseases::Liver Diseases::Fatty Liver::Non-alcoholic Fatty Liver Disease [DISEASES], [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, 3. Good health, Systems medicine, Obesitat, 030211 gastroenterology & hepatology, 0605 Microbiology, enfermedades del sistema digestivo::enfermedades hepáticas::hígado graso::esteatosis hepática no alcohólica [ENFERMEDADES], Microbiology (medical), medicine.medical_specialty, Iron, steatohepatitis, digestive system, Microbiology, Inorganic Chemicals::Iron Compounds::Iron, Dietary [CHEMICALS AND DRUGS], 03 medical and health sciences, [CHIM.ANAL]Chemical Sciences/Analytical chemistry, Internal medicine, medicine, Animals, Microbiome, Obesity, 030304 developmental biology, Ferritin, Gut microbiome, 0602 Ecology, Histidine transport, Nutritional and Metabolic Diseases::Nutrition Disorders::Overnutrition::Obesity [DISEASES], Research, Iron status, Fatty acid, Metabolism, biology.organism_classification, medicine.disease, Shotgun sequencing, Gastrointestinal Microbiome, Transplantation, Liver -- Diseases, Endocrinology, chemistry, enfermedades nutricionales y metabólicas::trastornos nutricionales::hipernutrición::obesidad [ENFERMEDADES], biology.protein, Metagenomics, Bacteroides, metabolism, Ferro, Non-alcoholic fatty liver disease

    وصف الملف: application/pdf